Showing results (31-40 of 101) with videos related to
Sort By:
Pageof 11
Internal Medicine (Tokyo, Japan)|November 3, 2009
Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemiaIppei Kanazawa, Toru Yamaguchi, Mika Yamauchi, et al.Diabetes Research and Clinical Practice|June 21, 2016
Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitusSayuri Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.Metabolism: Clinical and Experimental|April 15, 2011
Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitusToru Yamaguchi, Ippei Kanazawa, Shin Takaoka, et al.Journal of Bone and Mineral Metabolism|February 24, 2010
Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.Endocrine Journal|May 23, 2017
Association between the risk of falls and osteoporotic fractures in patients with type 2 diabetes mellitusMaki Yokomoto-Umakoshi, Ippei Kanazawa, Shiori Kondo, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 19, 2018
Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes MellitusKen-Ichiro Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 13, 2018
Higher Serum Uric Acid is a Risk Factor of Reduced Muscle Mass in Men with Type 2 Diabetes MellitusKen-Ichiro Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.Bone|November 13, 2016
Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitusKen-Ichiro Tanaka, Ippei Kanazawa, Hiroshi Kaji, et al.Therapeutic Advances in Endocrinology and Metabolism|May 2, 2019
Low skeletal muscle mass is associated with the risk of all-cause mortality in patients with type 2 diabetes mellitusHitomi Miyake, Ippei Kanazawa, Ken-Ichiro Tanaka, et al.Biochemical and Biophysical Research Communications|February 28, 2015
Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cellsKen-ichiro Tanaka, Toru Yamaguchi, Ippei Kanazawa, et al.Pageof 11